APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,280 | +22.0% | 3,898 | +192.2% | 0.00% | – |
| Q2 2023 | $121,528 | +40.5% | 1,334 | +1.8% | 0.00% | – |
| Q1 2023 | $86,473 | +134.2% | 1,311 | +83.6% | 0.00% | – |
| Q4 2022 | $36,921 | -87.3% | 714 | -83.3% | 0.00% | -100.0% |
| Q3 2022 | $291,000 | +1611.8% | 4,267 | +1069.0% | 0.00% | – |
| Q2 2022 | $17,000 | -69.6% | 365 | -67.1% | 0.00% | – |
| Q1 2022 | $56,000 | +409.1% | 1,110 | +391.2% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 226 | -34.1% | 0.00% | – |
| Q3 2021 | $12,000 | +33.3% | 343 | +145.0% | 0.00% | – |
| Q2 2021 | $9,000 | +125.0% | 140 | +30.8% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 107 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 107 | +256.7% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 30 | -58.9% | 0.00% | – |
| Q2 2020 | $2,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |